RB1 and inflammatory bowel disease: Although more research with a greater cohort is needed before immunohistochemical detection of phospho-RB and β-catenin could be routinely applicable as a laboratory test, our findings raise the possibility of using these proteins as potential molecular markers to help in the differentiation between CD and UC, and for elucidating unclassified-IBD cases.